Clinical TrialsSearch results
Number of results: 333
Other
- Randomized phase III study of 5-FU continuous infusion (5FUci) versus MTX+5-FU sequential therapy (MF) in gastric cancer with peritoneal metastasis (JCOG0106-MF, MF/5FU)
- gastric cancer with peritoneal metastasis
- Japan Clinical Oncology Group(JCOG)
- 2005-09-07
Other
- Randomized phase III study of 5-FU continuous infusion (5-FUci) versus CPT-11 plus CDDP (CP) versus S-1 alone (S-1) in advanced gastric cancer (JCOG9912)
- advanced or recurrent gastric cancer
- Japan Clinical Oncology Group(JCOG)
- 2005-08-16
Other
- Randomized phase II/III study of R-CHOP versus weekly rituximab plus CHOP for CD20 positive diffuse large B cell lymphoma (JCOG0601)
- CD20 positive diffuse large B cell lmyphoma
- Japan Clinical Oncology Group(JCOG)
- 2007-12-04
Other
- Randomized phase II trial of S-1 plus docetaxel combination versus single-agent docetaxel in platinum-pretreated patients with non-small-cell lung cancer
- platinum-pretreated patients with non-small-cell lung cancer
- Okayama Lung Cancer Study Group
- 2005-09-12
Other
- Randomized phase II trial of docetaxel and carboplatin in patients with stage IIIB/IV non-small cell lung cancer.
- Stage IIIB/IV non-small cell lung cancer
- The Japan-multinational Trial Organization
- 2008-07-01
Other
- Randomized phase II study of the Induction Chemotherapy with Docetaxel alone vs CDDP+Docetaxel for c-stage IB-II Non-Small Cell Lung Cancer (JCOG 0204-MF)
- pulmonary neoplasm
- Japan Clinical Oncology Group(JCOG)
- 2005-07-28
Other
- Randomized Phase II Study of Neoadjuvant Chemotherapy and Trastuzumab (Herceptin) for Operable Breast Cancer with Overexpression of HER2
- Breast Cancer
- Office for cordination of Herceptin trial
- 2007-03-23
Other
- Randomized phase II study of irinotecan and cisplatin or irinotecan, cisplatin and etoposide in patients with extensive small-cell lung cancer
- Extensive small-cell lung cancer
- Division of Medical Oncology, National Cancer Center Hospital
- 2006-06-01
Other
- Randomized phase II study of gemcitabine and S-1 combination therapy versus S-1 in advanced biliary tract cancer. (JCOG 0805)
- biliary tract neoplasm
- Japan Clinical Oncology Group(JCOG)
- 2009-02-04
Other
- Randomized phase II study of best available 5-FU versus low-dose Paclitaxiel in gastric cancer with peritoneal metastasis refractory to 5-FU containing regimen(JCOG0407)
- gastric neoplasm
- Japan Clinical Oncology Group(JCOG)
- 2005-09-08